Clinical Trial Update: Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AGA2115 in adults with Osteogenesis Imperfecta carrying COL1A1/COL1A2 variations; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteogenesis Imperfecta

Drugs mentioned

• AGA2115

Snippet

Sponsor: Angitia Incorporated Limited | Conditions: Osteogenesis Imperfecta (OI) | Phase 2 | Status: RECRUITING